Effect of Unani drug in comparison to Mefenamic Acid in Primary Dysmenorrhoea

Efficacy of Izkhar versus Mefenamic acid in primary dysmenorrhea- A Randomized Standard Controlled Trial - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100504

Enrollment

Registered

2026-01-07

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: Izkhar: After procurement and identification of Izkhar,decoction of Izkhar will be prepared by soaking 10g in 200ml of water overnight. The infusion will be boiled the following morning

Eligibility

Inclusion criteria

Inclusion criteria: Participants in the age of 15-35 years having painful menstruation of 1 to 2 episodes with VAS score (4-7) and VMSS score (1-2), with or without the associated symptoms (nausea, vomiting, fatigue, headache, giddiness, tenderness).

Exclusion criteria

Exclusion criteria: Pelvic pathology like uterine fibroid, endometriosis, adenomyosis, PID, PCOD, Systemic illnesses like HTN, DM, malignancies, Acute abdominal conditions like Peritonitis, Appendicitis, Renal and GB calculi, Heavy menstrual bleeding and severe anemia. Pregnant and lactating women Ectopic Pregnancy

Design outcomes

Primary

Measure	Time frame
Reduction in VAS score and VMSS gradingTimepoint: Baseline 4 week 8 week 12 week	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactProf Ismath Shameem

National Institute Of Unani Medicine

dr.ismaths@gmail.com9449977008

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026